Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO₂ recirculation using the closed abdomen technique (PRS-1.0 Combat): A clinical pilot study

References

• Jaaback K, Johnson N, Lawrie TA. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2011;11:CD005340.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis. Cancer 1977;39:2637–46.
   PubMed Web of Science ®Google Scholar
• El-Kareh AW, Secomb TW. A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance. Neoplasia 2004;6:117–27.
   PubMed Web of Science ®Google Scholar
• Glehen O, Cotte E, Kusamura S, Deraco M, Baratti D, Passot G, et al. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion. J Surg Oncol 2008;98:242–6.
   PubMed Web of Science ®Google Scholar
• Sanchez-Garcia S, Padilla-Valverde D, Villarejo-Campos P, Martin-Fernandez J, Garcia-Rojo M, Rodriguez-Martinez M. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system. Surgery 2014;155:719–25.
   PubMed Web of Science ®Google Scholar
• Jaaback K, Johnson N. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2006;CD005340.
   Google Scholar
• Elit L, Oliver TK, Covens A, Kwon J, Fung MF, Hirte HW, et al. Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses. Cancer 2007;109:692–702.
   PubMed Web of Science ®Google Scholar
• Landrum LM, Java J, Mathews CA, Lanneau GS Jr, Copeland LJ, Armstrong DK, Walker JL. Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol 2013;130:12–18.
   PubMed Web of Science ®Google Scholar
• Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:34–43.
   PubMed Web of Science ®Google Scholar
• de Bree E, Rosing H, Filis D, Romanos J, Melisssourgaki M, Daskalakis M, et al. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study. Ann Surg Oncol 2008;15:1183–92.
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee JM, Ryu KS, Lee YS, Park YG, Hur SY, et al. Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer. J Surg Oncol 2010;101:149–55.
   PubMed Web of Science ®Google Scholar
• Bae JH, Lee JM, Ryu KS, Lee YS, Park YG, Hur SY, et al. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. Gynecol Oncol 2007;106:193–200.
   PubMed Web of Science ®Google Scholar
• Cascales Campos PA, Gil Martinez J, Galindo Fernandez PJ, Gil Gomez E, Martinez Frutos IM, Parrilla Paricio P. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer. Eur J Surg Oncol 2011;37:543–8.
   PubMed Web of Science ®Google Scholar
• Rufian S, Munoz-Casares FC, Briceno J, Diaz CJ, Rubio MJ, Ortega R, et al. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer. J Surg Oncol 2006;94:316–24.
   PubMed Web of Science ®Google Scholar
• Ortega-Deballon P, Facy O, Magnin G, Piard F, Chauffert B, Rat P. Using a heating cable within the abdomen to make hyperthermic intraperitoneal chemotherapy easier: feasibility and safety study in a pig model. Eur J Surg Oncol 2010;36:324–8.
   PubMed Web of Science ®Google Scholar
• Esquivel J, Angulo F, Bland RK, Stephens AD, Sugarbaker PH. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open ‘Coliseum technique’. Ann Surg Oncol 2000;7:296–300
   PubMed Web of Science ®Google Scholar
• Kanakoudis F, Petrou A, Michaloudis D, Chortaria G, Konstantinidou A. Anaesthesia for intra-peritoneal perfusion of hyperthermic chemotherapy. Haemodynamic changes, oxygen consumption and delivery. Anaesthesia 1996;51:1033–6.
   PubMed Web of Science ®Google Scholar
• Litton E, Morgan M. The PiCCO monitor: a review. Anaesth Intensive Care 2012;40:393–409.
   PubMed Web of Science ®Google Scholar
• Cotte E, Glehen O, Mohamed F, Lamy F, Falandry C, Golfier F, et al. Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients. World J Surg 2007;31:1813–20.
   PubMed Web of Science ®Google Scholar
• Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 2008;113:315–25.
   PubMed Web of Science ®Google Scholar
• Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, et al. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol 2008;15:754–63.
   PubMed Web of Science ®Google Scholar
• Cheatham ML. Abdominal compartment syndrome: pathophysiology and definitions. Scand J Trauma Resusc Emerg Med 2009;17:10.
   PubMed Web of Science ®Google Scholar
• Facy O, Combier C, Poussier M, Magnin G, Ladoire S, Ghiringhelli F, Chaufert B, et al. High pressure does not counterbalance the advantages of open techniques over closed techniques during heated intraperitoneal chemotherapy with oxaliplatin. Surgery 2015;157:72–8.
   PubMed Web of Science ®Google Scholar
• Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol 2008;15:339–44.
   PubMed Web of Science ®Google Scholar
• Solass W, Kerb R, Mürdter T, Giger-Pabst U, Strumberg D, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 2014;21:553–9.
   PubMed Web of Science ®Google Scholar
• Zhou HM, Feng B, Zhao HC, Zheng MH. Antitumor effects of hyperthermic CO2 pneumoperitoneum on human gastric cancer cells. Asian Pac J Cancer Prev 2012;13:117–22
   PubMedGoogle Scholar
• Ma JJ, Feng B, Zhang Y, Li JW, Lu AG, Wang ML, et al. Higher CO2-insufflation pressure inhibits the expression of adhesion molecules and the invasion potential of colon cancer cells. World J Gastroenterol 2009;15:2714–22.
   PubMed Web of Science ®Google Scholar
• Schmidt C, Creutzenberg M, Piso P, Hobbhahn J, Bucher M. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia 2008;63:389–95.
   PubMed Web of Science ®Google Scholar
• Cooksley TJ, Haji-Michael P. Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC). World J Surg Oncol 2011;9:169.
   PubMed Web of Science ®Google Scholar
• Bell JC, Rylah BG, Chambers RW, Peet H, Mohamed F, Moran BJ. Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience. Ann Surg Oncol 2012;19:4244–51.
   PubMed Web of Science ®Google Scholar
• Webb CA, Weyker PD, Moitra VK, Raker RK. An overview of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for the anesthesiologist. Anesth Analg 2013;116:924–31.
   PubMed Web of Science ®Google Scholar
• Demiroluk S, Salihoglu Z, Bakan M, Bozkurt P. Effects of intraperitoneal and extraperitoneal carbon dioxide insufflation on blood gases during the perioperative period. J Laparoendosc Adv Surg Tech A 2004;14:219–22.
   PubMed Web of Science ®Google Scholar
• Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol 2009;135:1637–45.
   PubMed Web of Science ®Google Scholar
• Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 2007;18:1943–50.
   PubMed Web of Science ®Google Scholar
• Pavlov MJ, Kovacevic PA, Ceranic MS, Stamenkovic AB, Ivanovic AM, Kecmanovic DM. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer – 12-year single center experience. Eur J Surg Oncol 2009;35:1186–91.
   PubMed Web of Science ®Google Scholar
• Fagotti A, Paris I, Grimolizzi F, Fanfani F, Vizzielli G, Naldini A, et al. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study. Gynecol Oncol 2009;113:335–40.
   PubMed Web of Science ®Google Scholar
• Helm CW, Bristow RE, Kusamura S, Baratti D, Deraco M. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 2008 15;98:283–90.
   PubMed Web of Science ®Google Scholar